Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
China Taiping Insurance Holdings Company Limited (0966.HK)
Hong Kong, HK
China Taiping Insurance Holdings Company Limited, an investment holding company, underwrites various insurance and reinsurance products in the People's Republic of China, Hong Kong, Macau, Singapore, and internationally. The company operates through three segments: Life Insurance Business, Property and Casualty Insurance Business, and Reinsurance Business. The Life Insurance Business segment provides life insurance products, such as corporate and personal retirement insurance, group life insurance, individual insurance, health insurance, and accident insurance products and annuities. The Property and Casualty Insurance segment offers property and casualty insurance products, including compulsory motor insurance, liability insurance, credit insurance, guarantee insurance, and short-term accident and health insurance, as well as the related reinsurance products. The Reinsurance segment provides property damage, life, marine cargo and hull, and miscellaneous non-marine reinsurance products. The company also engages in the asset management, insurance intermediary, financial leasing, property investment, and securities dealing and broking, as well as in elderly care investment businesses; manages investment funds; and provides back-to-back financing arrangement, as well as insurance broking and agency services. The company was formerly known as China Insurance International Holdings Company Limited and changed its name to China Taiping Insurance Holdings Company Limited in August 2009. The company was incorporated in 2000 and is headquartered in North Point, Hong Kong. China Taiping Insurance Holdings Company Limited is a subsidiary of China Taiping Insurance Group (HK) Co. Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.40% | -4.38% | -10.82% | -13.08% | +14.39% | +6.31% | +64.76% | +138.25% | +38.95% | +35.91% | +1,157.59% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | -1 |
| Buy | 5 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Diversified: +15.2%+47.7% ★ Q4'25: +64.5% (vs Q4'23)
-
EPS growth Insurance - Diversified: +25.3%+250.2% ★ Q4'25: +4,138.5% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Diversified: +30.2%+99.2% Q4'25: +0.0% (vs Q4'23)
-
EBIT margin Insurance - Diversified: +13.5%+20.7% ★ Q4'25: +25.7% (vs Q4'23)
-
ROIC Insurance - Diversified: +4.2%+12.8% ★ Q4'25: +34.6% (vs Q4'23)
-
Share dilution Insurance - Diversified: +0.0%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Diversified: -0.05×4.97× Q4'25: 2.02× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 9 EPS Ana. |
Dec 2027 1 Rev. Ana. 9 EPS Ana. |
Dec 2028 1 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
162.25B
est: 128.06B (+26.7%)
|
167.59B
est: 148.70B (+12.7%)
|
197.87B
est: 172.58B (+14.7%)
|
214.19B
est: 193.76B (+10.5%)
|
246.54B
est: 219.11B (+12.5%)
|
277.07B
est: 227.69B (+21.7%)
|
318.98B
est: 248.66B (+28.3%)
|
158.81B
est: 279.87B (-43.3%)
|
106.12B
est: 269.94B (-60.7%)
|
121.00B
est: 111.03B (+9.0%)
|
178.68B
est: 114.53B (+56.0%)
|
129.90B
129.90B – 129.90B
+13.4% YoY
|
136.72B
136.72B – 136.72B
+5.2% YoY
|
154.10B
154.10B – 154.10B
+12.7% YoY
|
| EBITDA |
12.58B
est: 15.47B (-18.6%)
|
11.34B
est: 17.96B (-36.9%)
|
14.57B
est: 20.84B (-30.1%)
|
16.87B
est: 23.40B (-27.9%)
|
16.64B
est: 26.46B (-37.1%)
|
17.50B
est: 27.50B (-36.3%)
|
16.45B
est: 30.03B (-45.2%)
|
12.65B
est: 33.80B (-62.6%)
|
19.85B
est: 32.60B (-39.1%)
|
26.91B
est: 17.04B (+57.9%)
|
40.54B
est: 17.58B (+130.6%)
|
19.94B
19.94B – 19.94B
+13.4% YoY
|
20.99B
20.99B – 20.99B
+5.2% YoY
|
23.66B
23.66B – 23.66B
+12.7% YoY
|
| EBIT |
12.06B
est: 13.16B (-8.4%)
|
10.75B
est: 15.28B (-29.7%)
|
13.84B
est: 17.73B (-21.9%)
|
15.53B
est: 19.91B (-22.0%)
|
15.65B
est: 22.52B (-30.5%)
|
17.50B
est: 23.40B (-25.2%)
|
12.99B
est: 25.55B (-49.2%)
|
9.24B
est: 28.76B (-67.9%)
|
16.52B
est: 27.74B (-40.5%)
|
23.73B
est: 14.60B (+62.5%)
|
37.00B
est: 15.07B (+145.6%)
|
17.09B
17.09B – 17.09B
+13.4% YoY
|
17.98B
17.98B – 17.98B
+5.2% YoY
|
20.27B
20.27B – 20.27B
+12.7% YoY
|
| Net Income |
6.34B
est: 7.55B (-16.0%)
|
4.77B
est: 4.62B (+3.4%)
|
6.14B
est: 5.61B (+9.4%)
|
6.88B
est: 8.33B (-17.3%)
|
12.54B
est: 9.70B (+29.3%)
|
6.55B
est: 6.54B (+0.1%)
|
7.51B
est: 8.29B (-9.4%)
|
4.30B
est: 4.17B (+3.2%)
|
5.37B
est: 5.98B (-10.2%)
|
8.43B
est: 8.80B (-4.2%)
|
27.06B
est: 26.66B (+1.5%)
|
14.84B
10.87B – 18.31B
-44.3% YoY
|
16.41B
13.95B – 20.00B
+10.6% YoY
|
17.97B
17.97B – 17.97B
+9.5% YoY
|
| SGA |
23.39B
est: 11.53B (+102.9%)
|
22.68B
est: 13.39B (+69.4%)
|
27.71B
est: 15.54B (+78.3%)
|
31.01B
est: 17.45B (+77.7%)
|
35.28B
est: 19.73B (+78.8%)
|
34.25B
est: 20.50B (+67.1%)
|
34.42B
est: 22.39B (+53.7%)
|
31.03B
est: 25.20B (+23.1%)
|
2.48B
est: 24.31B (-89.8%)
|
—
est: 7.25B (-100.0%)
|
—
est: 7.48B (-100.0%)
|
8.49B
8.49B – 8.49B
+13.4% YoY
|
8.93B
8.93B – 8.93B
+5.2% YoY
|
10.07B
10.07B – 10.07B
+12.7% YoY
|
| EPS |
1.78
est: 2.10 (-15.3%)
|
1.27
est: 1.28 (-1.1%)
|
1.64
est: 1.56 (+5.1%)
|
1.92
est: 2.32 (-17.1%)
|
3.49
est: 2.70 (+29.3%)
|
1.82
est: 1.82 (+0.0%)
|
2.09
est: 2.31 (-9.4%)
|
1.20
est: 1.16 (+3.5%)
|
1.50
est: 1.67 (-9.9%)
|
2.07
est: 2.45 (-15.5%)
|
7.25
est: 7.42 (-2.3%)
|
4.13
3.02 – 5.09
-44.3% YoY
|
4.57
3.88 – 5.57
+10.6% YoY
|
5.00
5.00 – 5.00
+9.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-28 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-27 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-26 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-22 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-21 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 3/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 3/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 3/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 3/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VictoryShares International Value Momentum ETF UIVM | 0.37% | 1.21M | 0.39% |
| 2 | Vident International Equity Strategy ETF VIDI | 0.35% | 1.39M | 0.61% |
| 3 | Rayliant Wilshire NxtGen Emerging Markets Equity ETF RWEM | 0.35% | 273.3K | 0.52% |
| 4 | Avantis Emerging Markets Value ETF AVES | 0.30% | 4.38M | 0.36% |
| 5 | iShares Ageing Population UCITS ETF AGED.L | 0.28% | 2.51M | 0.40% |
| 6 | FlexShares International Quality Dividend Index Fund IQDF | 0.16% | 1.85M | 0.49% |
| 7 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.15% | 174.1K | 0.42% |
| 8 | Xtrackers MSCI China UCITS ETF 1D XCS7.L | 0.14% | 2.79M | 0.28% |
| 9 | Xtrackers MSCI China UCITS ETF 1C XCS6.L | 0.14% | 2.79M | 0.65% |
| 10 | Global X MSCI China ETF (HKD) 3040.HK | 0.14% | 76.9K | 0.18% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Zhaojun Yin | Executive Chairman | 1M | male |
| Kedong Li | GM & Executive Vice Chairman of the Board | 1M | male |
| Yanfang Na | Executive Director | 519.0K | male |
| Yanjun Jiao | Chief Internal Auditor | — | male |
| Ruohan Zhang | Chief Financial Officer & Company Secretary | — | male |
| Qingming Li | Chief Business Officer | — | male |
| Cynthia Choi | Head of Investor Relations | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0966.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
